« FDA Warns Three Pharmacies To Stop Mass-Producing Unapproved Inhalation Drugs | Main | Omeros Names Greg Perkins, Ph.D., as Vice President, Regulatory Affairs »

FDA Approvals - Kensey Nash Reports Fourth Quarter and Fiscal Year 2006 Results


Kensey Nash Reports Fourth Quarter and Fiscal Year 2006 Results Including Record Fourth Quarter Sales and Revenues (FinanzNachrichten)
EXTON, Pa., Aug. 21 /PRNewswire-FirstCall/ -- Kensey Nash Corporation ( Nachrichten ) today reported results for its fourth quarter of fiscal year 2006, which were at the high end of previously announced estimates.

United Research Laboratories/Mutual Pharmaceutical Company Announce ANDA Filing For Guaifenesin Extended-Release (Medical News Today)
United Research Laboratories andMutual Pharmaceutical Company today announce that Mutual has filed anAbbreviated New Drug Application (ANDA) with the Food and DrugAdministration (FDA), seeking approval to market Mutual's guaifenesinextended-release tablets, 600 mg and 1200 mg. [click link for full article]
 

©2006 FDA-News.com. All rights reserved.